Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study (Q44569444)

4 December 2017

title

Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study (English)

1 reference

4 December 2017

main subject

autism spectrum disorder

0 references

0 references

3

1 reference

4 December 2017

4

1 reference

4 December 2017

5

Jan K Buitelaar

1 reference

4 December 2017

Yingfen Hsia

1

0 references

author name string

Angel Y S Wong

series ordinal

2

1 reference

4 December 2017

Ian C K Wong

series ordinal

6

1 reference

4 December 2017

publication date

5 September 2013

1 reference

4 December 2017

1 reference

4 December 2017

volume

231

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

999-1009

1 reference

Review on the current use of antipsychotic drugs in children and adolescents.

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Episodic psychiatric disorders in teenagers with learning disabilities with and without autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Caregiver burden as people with autism spectrum disorder and attention-deficit/hyperactivity disorder transition into adolescence and adulthood in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Use of psychotropic medication in children and adolescents with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

21 January 2018

The prevalence of autism

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Targeted treatments for symptom domains in child and adolescent autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

A Double-Blind Placebo-Controlled Trial of Fluoxetine for Repetitive Behaviors and Global Severity in Adult Autism Spectrum Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

High Prescription Drug Use and Associated Costs among Medicaid-Eligible Children with Autism Spectrum Disorders Identified by a Population-Based Surveillance Network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Anxiety in children and adolescents with Autism Spectrum Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

A systematic review of medical treatments for children with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Use of clonidine in children with autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Management of Children With Autism Spectrum Disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Antipsychotics in the treatment of autism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Mortality in children and adolescents prescribed antipsychotic medication: a retrospective cohort study using the UK general practice research database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Risk of hyperprolactinemia and sexual side effects in males 10-20 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Bone mineral density in male adolescents with autism spectrum disorders and disruptive behavior disorder with or without antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Antipsychotic-Induced Hyperprolactinemia and Testosterone Levels in Boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Melatonin in autism spectrum disorders: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Selective serotonin reuptake inhibitors for the treatment of autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Psychotropic Medication Use in Children With Autism in the Kentucky Medicaid Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

The potential of UK clinical databases in enhancing paediatric medication research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Increased prescribing trends of paediatric psychotropic medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

A three-country comparison of psychotropic medication prevalence in youth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Paediatric Atypical Antipsychotic Monitoring Safety (PAMS) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

Rhabdomyolysis Reported for Children and Adolescents Treated with Antipsychotic Medicines: A Case Series Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00213-013-3263-X

A review of complementary and alternative treatments for autism spectrum disorders

21 January 2018

1 reference

12 December 2020

Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study

1 reference

12 December 2020

Primary care for children with autism

1 reference

12 December 2020

Classification of autism and related conditions: progress, challenges, and opportunities

1 reference

12 December 2020

Assessment of the use of angiotensin receptor blockers in major European markets among paediatric population for treating essential hypertension

1 reference

12 December 2020

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

1 reference

12 December 2020

Sleep behaviors and sleep quality in children with autism spectrum disorders.

1 reference

12 December 2020

10.1007/S00213-013-3263-X

Identifiers

DOI

1 reference

4 December 2017

1 reference